Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer.
Filipe La Fuente CarvalhoAlexander ZeymoJillian EganColleen H KellyChaoyi ZhengJohn H LynchJonathan HwangLambros StamatakisRoss E KrasnowKeith J KowalczykPublished in: Investigative and clinical urology (2020)
Our study demonstrates that NAC is underutilized. Decreased utilization of NAC was associated with older patients and higher Charlson score. This underutilization may be related to practice patterns as very few patients have true contraindications.